Vancouver, British Columbia–(Newsfile Corp. – February 24, 2022) – Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (the “ Acquiror“) announces, pursuant to the early warning requirements of Canadian securities legislation, that on February 22, 2022 and February 23, 2022, it sold a total of 4,500,000 common shares in the capital of Ionic Brands Corp. (the “Issuer” and the common shares of the Issuer…

Source

Previous articleHAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research
Next articleEntheon Biomedical Announces EBIQ-101 First-Patient Dose